Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Gritstone bio Inc.

    NASDAQ: GRTS · Real-Time Price · USD
    0.03
    -0.02 (-36.44%)
    At close: Oct 21, 2024, 8:00 PM

    Gritstone bio Statistics

    Share Statistics

    Gritstone bio has 118.11M shares outstanding. The number of shares has increased by 8.79% in one year.

    Shares Outstanding

    n/a
    		 118.11M

    Shares Change (YoY)

    n/a
    		 8.79%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 32.93%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 12,800

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.7 and the forward PE ratio is null. Gritstone bio's PEG ratio is 0.53.

    PE Ratio

    n/a
    		 -1.7

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 177.07

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 4.55

    P/FCF Ratio

    n/a
    		 -1.87

    PEG Ratio

    n/a
    		 0.53
    Financial Ratio History

    Enterprise Valuation

    Gritstone bio has an Enterprise Value (EV) of 275.17M.

    EV / Sales

    n/a
    		 206.74

    EV / EBITDA

    n/a
    		 -2.17

    EV / EBIT

    n/a
    		 -2.26

    EV / FCF

    n/a
    		 -2.18

    Financial Position

    The company has a current ratio of 3.2, with a Debt / Equity ratio of 0.91.

    Current Ratio

    n/a
    		 3.2

    Quick Ratio

    n/a
    		 3.2

    Debt / Equity

    n/a
    		 0.91

    Debt / EBITDA

    n/a
    		 -0.83

    Debt / FCF

    n/a
    		 -0.83

    Interest Coverage

    n/a
    		 -38.31

    Financial Efficiency

    Return on Equity is -267.1% and Return on Invested Capital is -164.74%.

    Return on Equity

    n/a
    		 -267.1%

    Return on Assets

    n/a
    		 -77.9%

    Return on Invested Capital

    n/a
    		 -164.74%

    Revenue Per Employee

    n/a
    		 $5,761.9

    Profits Per Employee

    n/a
    		 $-599,523.81

    Employee Count

    n/a
    		 231

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 7.42M

    Effective Tax Rate

    n/a
    		 -5.36%

    Stock Price Statistics

    The stock price has increased by -96.31% in the last 52 weeks. The beta is 0.5, so Gritstone bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.5

    52-Week Price Change

    n/a
    		 -96.31%

    50-Day Moving Average

    n/a
    		 0.22

    200-Day Moving Average

    n/a
    		 0.91

    Relative Strength Index (RSI)

    n/a
    		 26.36

    Average Volume (20 Days)

    n/a
    		 17,011,671

    Income Statement

    In the last 12 months, Gritstone bio had revenue of 1.33M and earned -138.49M in profits. Earnings per share was -1.2.

    Revenue

    n/a
    		 1.33M

    Gross Profit

    n/a
    		 -6.26M

    Operating Income

    n/a
    		 -154.63M

    Net Income

    n/a
    		 -138.49M

    EBITDA

    n/a
    		 -126.86M

    EBIT

    n/a
    		 -134.45M

    Earnings Per Share (EPS)

    n/a
    		 -1.2
    Full Income Statement

    Balance Sheet

    The company has 65.28M in cash and 104.78M in debt, giving a net cash position of -39.49M.

    Cash & Cash Equivalents

    n/a
    		 65.28M

    Total Debt

    n/a
    		 104.78M

    Net Cash

    n/a
    		 -39.49M

    Retained Earnings

    n/a
    		 -659.56M

    Total Assets

    n/a
    		 142.54M

    Working Capital

    n/a
    		 36.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -121.65M and capital expenditures -4.57M, giving a free cash flow of -126.22M.

    Operating Cash Flow

    n/a
    		 -121.65M

    Capital Expenditures

    n/a
    		 -4.57M

    Free Cash Flow

    n/a
    		 -126.22M

    FCF Per Share

    n/a
    		 -1.09
    Full Cash Flow Statement

    Margins

    Gross margin is -470.32%, with operating and profit margins of -11617.88% and -10404.96%.

    Gross Margin

    n/a
    		 -470.32%

    Operating Margin

    n/a
    		 -11617.88%

    Pretax Margin

    n/a
    		 -10404.96%

    Profit Margin

    n/a
    		 -10404.96%

    EBITDA Margin

    n/a
    		 -9531.4%

    EBIT Margin

    n/a
    		 -11617.88%

    FCF Margin

    n/a
    		 -9483.1%

    Dividends & Yields

    GRTS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -58.76%

    FCF Yield

    n/a
    		 -53.56%
    Dividend Details

    Analyst Forecast

    The average price target for GRTS is $0.75, which is 2400% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $0.75

    Price Target Difference

    n/a
    		 2400%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.73

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist